SHR-1819
N/A
Report date: 2026/04/30 20:00:20
Base Information
Drug NameSHR-1819
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesGuangdong Hengrui Pharmaceutical Co LtdAtridia Pty LtdShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications +[9]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A